Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

Health Canada approves drug treatment for rare disease

Elfabrio was authorized after clinical trials with over 140 patients showed it protects kidney function comparably to existing therapies for this progressive inherited disorder.

Summary by CTV News
Health Canada has approved a new drug treatment for adults living with Fabry disease, a rare genetic disorder that can affect multiple organs and impact the quality of life.

2 Articles

CTV NewsCTV News
Reposted by
CP24CP24
Center

Health Canada approves drug treatment for rare disease

Health Canada has approved a new drug treatment for adults living with Fabry disease, a rare genetic disorder that can affect multiple organs and impact the quality of life.

·Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CTV News broke the news in Canada on Tuesday, December 16, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Health Canada icon

Health Canada

Positive News icon

Positive News

Health Care icon

Health Care

Health icon

Health

Canadian Healthcare icon

Canadian Healthcare

Canada icon

Canada

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal